The pharmaceutical industry has grown accustomed to investing billions of dollars to bring drugs to market, only to watch 90 percent of them fail even before clinical trials. The problem is, and always has been, there’s simply not enough compute power in the world to accurately assess the properties of all possible molecules, nor to Read article >
The post Schrödinger Transforming Drug Discovery with GPU-Powered Platform appeared first on The Official NVIDIA Blog.
- View Press Release
- Visit NVIDIA Corporation